Companies / Janux Therapeutics, Inc. / Activity
Activity — Janux Therapeutics, Inc.
28 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Barrett Ronald W Director | Grant | Common Stock | $0 | +6K +88.00% | 11,750 0.02% of shares | low |
| Jun 11, 2026 | RA Capital Management, L.P. Director | Grant | Common Stock | $0 | +6K +88.00% | 11,750 0.02% of shares | low |
| Jun 11, 2026 | Capps Vickie L Director | Grant | Common Stock | $0 | +6K +7.42% | 79,598 0.13% of shares | low |
| Jun 11, 2026 | Dobmeier Eric Director | Grant | Common Stock | $0 | +6K +55.10% | 15,481 0.03% of shares | low |
| Feb 2, 2026 | Go William Executive | Grant | Common Stock | $0 | +44K | 44,000 0.07% of shares | low |
| Jan 2, 2026 | Doyle Janeen Noel Executive | Grant | Common Stock | $0 | +36K +81.82% | 80,000 0.13% of shares | low |
| Jan 2, 2026 | McIver Zachariah Executive | Grant | Common Stock | $0 | +29K +124.54% | 52,286 0.09% of shares | low |
| Jan 2, 2026 | Dobek Maria Executive | Grant | Common Stock | $0 | +19K +123.17% | 34,308 0.06% of shares | low |
| Jan 2, 2026 | DiRaimondo Thomas Executive | Grant | Common Stock | $0 | +31K +25.24% | 155,825 0.25% of shares | low |
| Jan 2, 2026 | Winter Charles M. Executive | Grant | Common Stock | $0 | +29K +36.80% | 106,321 0.17% of shares | low |
| Jan 2, 2026 | Campbell David Alan CEO | Grant | Common Stock | $0 | +97K +33.90% | 381,582 0.62% of shares | low |
| Jan 2, 2026 | Dobek Maria Executive | Sell | Common Stock | $20.1K | -1K -8.68% | 15,373 0.03% of shares | low |
| Jan 2, 2026 | Meyer Andrew Hollman Executive | Sell | Common Stock | $25.8K | -2K -2.21% | 83,095 0.14% of shares | low |
| Jan 2, 2026 | Winter Charles M. Executive | Sell | Common Stock | $33.0K | -2K -3.00% | 77,721 0.13% of shares | low |
| Jan 2, 2026 | DiRaimondo Thomas Executive | Sell | Common Stock | $34.4K | -3K -1.97% | 124,425 0.20% of shares | low |
| Jan 2, 2026 | McIver Zachariah Executive | Sell | Common Stock | $37.3K | -3K -10.44% | 23,286 0.04% of shares | low |
| Jan 2, 2026 | Campbell David Alan CEO | Sell | Common Stock | $110.8K | -8K -2.75% | 284,982 0.47% of shares | medium |
| Jun 11, 2026 | Barrett Ronald W Director | Grant | Stock Option (right to buy) | — | +16K | 15,500 0.03% of shares | low |
| Jun 11, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +16K | 15,500 0.03% of shares | low |
| Jun 11, 2026 | Capps Vickie L Director | Grant | Stock Option (right to buy) | — | +16K | 15,500 0.03% of shares | low |
| Jun 11, 2026 | Dobmeier Eric Director | Grant | Stock Option (right to buy) | — | +16K | 15,500 0.03% of shares | low |
| Feb 2, 2026 | Go William Executive | Grant | Stock option (right to buy) | — | +154K | 154,000 0.25% of shares | low |
| Jan 2, 2026 | Doyle Janeen Noel Executive | Grant | Stock option (right to buy) | — | +126K | 126,000 0.21% of shares | low |
| Jan 2, 2026 | McIver Zachariah Executive | Grant | Stock option (right to buy) | — | +102K | 101,500 0.17% of shares | low |
| Jan 2, 2026 | Dobek Maria Executive | Grant | Stock option (right to buy) | — | +43K | 42,600 0.07% of shares | low |
| Jan 2, 2026 | DiRaimondo Thomas Executive | Grant | Stock option (right to buy) | — | +110K | 109,900 0.18% of shares | low |
| Jan 2, 2026 | Winter Charles M. Executive | Grant | Stock option (right to buy) | — | +100K | 100,100 0.16% of shares | low |
| Jan 2, 2026 | Campbell David Alan CEO | Grant | Stock option (right to buy) | — | +338K | 338,100 0.55% of shares | low |